Copyright
©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Sep 14, 2006; 12(34): 5473-5478
Published online Sep 14, 2006. doi: 10.3748/wjg.v12.i34.5473
Published online Sep 14, 2006. doi: 10.3748/wjg.v12.i34.5473
-765G > C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia
Carina Pereira, Paula Ferreira, Molecular Oncology Group, Portuguese Institute of Oncology of Porto, Portugal
Maria Fragoso, Oncology Department, Portuguese Institute of Oncology of Porto, Portugal
Luís Moreira-Dias, Gastroenterology Department, Portuguese Institute of Oncology of Porto, Portugal
Hugo Sousa, Carlos Lopes, Rui Medeiros, Molecular Oncology Group, Portuguese Institute of Oncology of Porto, Portugal; and ICBAS, Abel Salazar Institute for the Biomedical Sciences, Porto, Portugal
Mário Dinis-Ribeiro, Gastroenterology Department, Portuguese Institute of Oncology of Porto, Portugal; and Cintesis / Faculty of Medicine University of Porto, Porto, Portugal
Supported by the Portuguese League Against Cancer (Liga Portuguesa Contra o Cancro-Núcleo Regional do Norte) and AstraZeneca Foundation
Correspondence to: Mário Dinis-Ribeiro, MD, PhD, Serviço de Gastrenterologia, Instituto Português de Oncologia do Porto FG EPE, Rua Dr. António Bernardino Almeida, 4200-072 Porto, Portugal. mario@med.up.pt
Telephone: +351-22-5084000-348 Fax: +351-22-5084001
Received: May 12, 2006
Revised: May 28, 2006
Accepted: June 16, 2006
Published online: September 14, 2006
Revised: May 28, 2006
Accepted: June 16, 2006
Published online: September 14, 2006
Core Tip